Allurion Technologies (ALURW) Cash & Equivalents (2022 - 2026)

Allurion Technologies (ALURW) has 5 years of Cash & Equivalents data on file, last reported at $5.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 75.23% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (down 75.23% YoY), and the FY2025 full-year result was $5.4 million, down 64.81% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $5.1 million, down from $5.4 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $79.9 million in Q3 2023 and bottomed at $4.7 million in Q2 2023.
• The 5-year median for Cash & Equivalents is $15.4 million (2024), against an average of $21.0 million.
• The widest annual swing landed in 2023, when Cash & Equivalents soared 394.95%; it then sank 78.59% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $7.7 million in 2022, then jumped by 394.95% to $38.0 million in 2023, then tumbled by 59.57% to $15.4 million in 2024, then plunged by 64.81% to $5.4 million in 2025, then dropped by 6.58% to $5.1 million in 2026.
• The last three Cash & Equivalents figures came in at $5.1 million (Q1 2026), $5.4 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.

Peer Comparison